Functional Analysis LRP6 Novel Mutations in Patients with Coronary Artery Disease

被引:21
|
作者
Xu, Yujun [1 ,2 ,3 ]
Gong, Wei [1 ,2 ]
Peng, Jia [1 ,2 ,4 ]
Wang, Haoran [1 ,2 ]
Huang, Jin [1 ,2 ]
Ding, Hu [1 ,2 ,5 ]
Wang, Dao Wen [1 ,2 ,5 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China
[3] Sichuan Univ, West China Hosp, Intens Care Unit, Chengdu 610064, Peoples R China
[4] Sichuan Prov Hosp, Echocardiog Lab, Chengdu, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Genet Diag Ctr, Wuhan 430074, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 01期
关键词
RECEPTOR-RELATED PROTEIN-5; MUSCLE-CELL PROLIFERATION; LOW-DENSITY-LIPOPROTEIN; BETA-CATENIN; ATHEROSCLEROSIS; ANGIOGENESIS; MECHANISMS; VARIANTS; PATHWAYS; FAMILY;
D O I
10.1371/journal.pone.0084345
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Genetic architecture of coronary artery disease (CAD) is still to be defined. Since low density lipoprotein receptor-related protein 6 (LRP6) gene play critical roles in Wnt signal transduction which are important for vascular development and endodermis specification, we therefore resequenced it to search for mutations in CAD patients. Methods: We systemically sequenced all the exons and promoter region of LRP6 gene in a sample of 380 early onset CAD patients and 380 control subjects in Chinese. Results: In total, we identified 5 patient-specific mutations including K82N (two patients), S488Y (one patient), P1066T (two patients), P1206H (two patients) and I1264V (one patient) All these mutations located at the extracellular domain of LRP6 gene. In vitro functional analysis of patient-specific mutations demonstrated that these mutations resulted in a significant reduction in both protein level transporting to cell membrane and downstream Wnt signal activity. Furthermore, we found that LRP6 novel mutations attenuated proliferation and migration of human umbilical vein endothelial cells (HUVECs) when compared with wild type (WT) LRP6. Conclusion: Our results demonstrated that these loss-of-function variants might contribute to disease liability in a subset of CAD and defects in Wnt signal activation might be important contributing factors for the onset of CAD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Structural and Functional Studies of LRP6 Ectodomain Reveal a Platform for Wnt Signaling
    Chen, Shuo
    Bubeck, Doryen
    MacDonald, Bryan T.
    Liang, Wen-Xue
    Mao, Jian-Hua
    Malinauskas, Tomas
    Llorca, Oscar
    Aricescu, A. Radu
    Siebold, Christian
    He, Xi
    Jones, E. Yvonne
    DEVELOPMENTAL CELL, 2011, 21 (05) : 848 - 861
  • [32] A new LRP6 variant and Camurati-Engelmann-like disease
    Pickering, Marie-Eva
    Ltaief-Boudrigua, Aicha
    Feurer, Elodie
    Collet, Corinne
    Chapurlat, Roland
    BONE, 2021, 143
  • [33] A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor
    Liu, GZ
    Bafico, A
    Harris, VK
    Aaronson, SA
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (16) : 5825 - 5835
  • [34] Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6
    Fleury, Damien
    Vayssiere, Beatrice
    Touitou, Robert
    Gillard, Corinne
    Lebhar, Helene
    Rawadi, Georges
    Mollat, Patrick
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 70 (01) : 39 - 47
  • [35] Functional interactions between the LRP6 WNT co-receptor and folate supplementation
    Gray, Jason D.
    Nakouzi, Ghunwa
    Slowinska-Castaldo, Bozena
    Dazard, Jean-Eudes
    Rao, J. Sunil
    Nadeau, Joseph H.
    Ross, M. Elizabeth
    HUMAN MOLECULAR GENETICS, 2010, 19 (23) : 4560 - 4572
  • [36] Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6
    Abrami, Laurence
    Kunz, Beatrice
    Deuquet, Julie
    Bafico, Anna
    Davidson, Gary
    van der Goot, F. Gisou
    CELLULAR MICROBIOLOGY, 2008, 10 (12) : 2509 - 2519
  • [38] Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis
    van Meurs, Joyce B. J.
    Trikalinos, Thomas A.
    Ralston, Stuart H.
    Balcells, Susana
    Brandi, Maria Luisa
    Brixen, Kim
    Kiel, Douglas P.
    Langdahl, Bente L.
    Lips, Paul
    Ljunggren, Osten
    Lorenc, Roman
    Obermayer-Pietsch, Barbara
    Ohlsson, Claes
    Pettersson, Ulrika
    Reid, David M.
    Rousseau, Francois
    Scollen, Serena
    Van Hul, Wim
    Agueda, Lidia
    Akesson, Kristina
    Benevolenskaya, Lidia I.
    Ferrari, Serge L.
    Hallmans, Goran
    Hofman, Albert
    Husted, Lise Bjerre
    Kruk, Marcin
    Kaptoge, Stephen
    Karasik, David
    Karlsson, Magnus K.
    Lorentzon, Mattias
    Masi, Laura
    McGuigan, Fiona E. A.
    Mellstrom, Dan
    Mosekilde, Leif
    Nogues, Xavier
    Pols, Huibert A. P.
    Reeve, Jonathan
    Renner, Wilfried
    Rivadeneira, Fernando
    van Schoor, Natasja M.
    Weber, Kurt
    Ioannidis, John P. A.
    Uitterlinden, Andre G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11): : 1277 - 1290
  • [39] Novel variant in LRP6 associated with unusual and severe clinical presentation: Case report
    Previdi, Anaik
    Dubourg, Christele
    Daire, Valerie Cormier
    Fradin, Melanie
    Collet, Corinne
    CLINICAL GENETICS, 2024, 105 (06) : 666 - 670
  • [40] Heterodimerization of VLDLR and LRP6: A novel mechanism for the inhibition of the Wnt/β-catenin pathway.
    Shin, Younghwa
    Lee, Kyungwon
    Cheng, Rui
    Park, Kyungmin
    Hu, Yang
    Mcbride, Jeffrey
    He, Xuemin
    Takahashi, Yusuke
    Ma, Jian-xing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)